The Restriction Endonucleases Products market was valued at USD 375.29 Million in 2022 and is expected to reach USD 598.16 Million by 2030, growing at a CAGR of 6% (2023-2030). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.